http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2355197-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02a1ce47d761b62b20a3da4a016b13dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N59-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-00
filingDate 1999-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c714f8dc4fb948166c78894a31c47317
publicationDate 2001-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2355197-A
titleOfInvention A dry powder/solid formulation for dissolving in water and subsequent use as a chlorine releasing sterilant
abstract A disinfectant/sterilising formulation is provided as a dry powder/solid which comprises a chlorine releasing compound (which will release chlorine on contact with water) so that the formulation, when dissolved in water, produces a near neutral biocidally active solution. The chlorine releasing compound is preferably sodium dichloroisocyanurate and the formulation preferably further comprises an alkali or alkaline metal chlorite (eg sodium chlorite). Release of chlorine dioxide from the chlorite is triggered by the release of chlorine when the formulation is dissolved in water. Chlorine dioxide is a very powerful oxidising agent and an excellent bactericide, which is normally produced by a highly acidic reaction with sodium chlorite. The formulation may also incorporate a buffer, a desiccant (to provide storage stability), a surfactant, a filler (to maintain and bulk the composition), a tableting aid, a sequestrant (to aid effectiveness of formulation if used with hard dilution water) and a corrosion inhibitor. The formulation is primarily intended for use in sterilising medical and dental instuments and as a high level disinfectant in hospital, veterinary and food establishments. It is also intended for areas where the utmost hygiene is required.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009528351-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008057067-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2426708-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105668730-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2426708-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9340756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009541197-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8673297-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008057067-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101409142-B1
priorityDate 1999-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06157222-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4104190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5738840-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2263108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0081962-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID197148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411211448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453058690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668197

Total number of triples: 39.